Item Type | Name |
Concept
|
Breast Neoplasms
|
Concept
|
Breast Neoplasms, Male
|
Academic Article
|
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
|
Academic Article
|
microRNA, cell cycle, and human breast cancer.
|
Academic Article
|
Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.
|
Academic Article
|
microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling.
|
Academic Article
|
Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling".
|
Academic Article
|
ErbB2 induces Notch1 activity and function in breast cancer cells.
|
Academic Article
|
Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors.
|
Academic Article
|
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
|
Academic Article
|
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.
|
Academic Article
|
Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism.
|
Academic Article
|
Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NF?B activation in the tumor stromal microenvironment.
|
Academic Article
|
The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.
|
Academic Article
|
HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.
|
Academic Article
|
Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
|
Academic Article
|
Alternative cyclin D1 splice forms differentially regulate the DNA damage response.
|
Academic Article
|
Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics.
|
Academic Article
|
Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.
|
Academic Article
|
The role of breast cancer stem cells in metastasis and therapeutic implications.
|
Academic Article
|
Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis.
|
Academic Article
|
Examining the role of cyclin D1 in breast cancer.
|
Academic Article
|
Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer".
|
Academic Article
|
Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells.
|
Academic Article
|
Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors.
|
Academic Article
|
Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
|
Academic Article
|
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.
|
Academic Article
|
Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.
|
Academic Article
|
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.
|
Academic Article
|
Breast cancer stem cells.
|
Academic Article
|
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.
|
Academic Article
|
Small non-coding RNAs govern mammary gland tumorigenesis.
|
Academic Article
|
CCR5 antagonist blocks metastasis of basal breast cancer cells.
|
Academic Article
|
Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production.
|
Academic Article
|
CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth.
|
Academic Article
|
Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.
|
Academic Article
|
Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1a and HIF2a in tumor-associated fibroblasts and human breast cancer cells.
|
Academic Article
|
Compartment-specific activation of PPAR? governs breast cancer tumor growth, via metabolic reprogramming and symbiosis.
|
Academic Article
|
EYA1 Phosphatase Function Is Essential to Drive Breast Cancer Cell Proliferation through Cyclin D1.
|
Academic Article
|
Caloric restriction augments radiation efficacy in breast cancer.
|
Academic Article
|
Acetylation of the Cell-Fate Factor Dachshund Determines p53 Binding and Signaling Modules in Breast Cancer.
|
Academic Article
|
p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
|
Academic Article
|
Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
|
Academic Article
|
Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.
|
Academic Article
|
Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice.
|
Academic Article
|
BRCA1 gene in breast cancer.
|
Academic Article
|
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
|
Academic Article
|
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.
|
Academic Article
|
BRCA1 in hormone-responsive cancers.
|
Academic Article
|
p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.
|
Academic Article
|
AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.
|
Academic Article
|
BRCA1 inhibition of telomerase activity in cultured cells.
|
Academic Article
|
Altered Rho GTPase signaling pathways in breast cancer cells.
|
Academic Article
|
The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
|
Academic Article
|
Caveolin-1 in breast cancer.
|
Academic Article
|
Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells.
|
Academic Article
|
Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose.
|
Academic Article
|
Mayven induces c-Jun expression and cyclin D1 activation in breast cancer cells.
|
Academic Article
|
Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2.
|
Academic Article
|
Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
|
Academic Article
|
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
|
Academic Article
|
Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.
|
Academic Article
|
Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.
|
Academic Article
|
Regulation of progesterone receptor signaling by BRCA1 in mammary cancer.
|
Academic Article
|
DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.
|
Academic Article
|
Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
|
Academic Article
|
The functional significance of nuclear receptor acetylation.
|
Academic Article
|
Akt1 governs breast cancer progression in vivo.
|
Academic Article
|
Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1.
|
Academic Article
|
Stabilization of SMAR1 mRNA by PGA2 involves a stem loop structure in the 5' UTR.
|
Academic Article
|
Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy.
|
Academic Article
|
Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8.
|
Academic Article
|
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
|
Academic Article
|
Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.
|
Academic Article
|
Cancer stem cells and the cell cycle: targeting the drive behind breast cancer.
|
Academic Article
|
Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders.
|
Academic Article
|
Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation.
|
Academic Article
|
Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.
|
Academic Article
|
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.
|
Academic Article
|
Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy.
|
Academic Article
|
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer.
|
Academic Article
|
PPARgamma activation induces autophagy in breast cancer cells.
|
Academic Article
|
The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
|
Academic Article
|
p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.
|
Academic Article
|
BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.
|
Academic Article
|
The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.
|
Academic Article
|
Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.
|
Academic Article
|
Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer.
|
Academic Article
|
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer.
|
Academic Article
|
CAPER, a novel regulator of human breast cancer progression.
|
Academic Article
|
miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1.
|
Academic Article
|
Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer.
|
Academic Article
|
pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.
|
Academic Article
|
BRCA1 inhibition of estrogen receptor signaling in transfected cells.
|
Academic Article
|
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression.
|
Academic Article
|
The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
|
Academic Article
|
The mammary gland iodide transporter is expressed during lactation and in breast cancer.
|
Academic Article
|
Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycle.
|
Academic Article
|
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
|
Academic Article
|
Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis.
|
Academic Article
|
Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS).
|
Academic Article
|
Nutritional modulation of the cell cycle and breast cancer.
|
Academic Article
|
miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer.
|
Academic Article
|
The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster.
|
Academic Article
|
Acetylation-defective mutant of Ppar? is associated with decreased lipid synthesis in breast cancer cells.
|
Academic Article
|
The potential to target CCL5/CCR5 in breast cancer.
|
Academic Article
|
BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion.
|
Academic Article
|
EglN2 associates with the NRF1-PGC1a complex and controls mitochondrial function in breast cancer.
|
Academic Article
|
Mitochondrial mass and DNA repair in breast cancer stem cells.
|
Academic Article
|
Breast Cancer Stem Cell Isolation.
|
Academic Article
|
Cancer stem cell metabolism.
|
Academic Article
|
A direct quantification method for measuring plasma MicroRNAs identified potential biomarkers for detecting metastatic breast cancer.
|
Academic Article
|
The CCL5/CCR5 axis promotes metastasis in basal breast cancer.
|
Grant
|
BREAST INDUCIBLE ANTISENSE CYCLIN D1 TRANSGENIC MICE
|
Grant
|
Cyclin D1 Regulation of Nuclear Receptor Function in Breast Cancer
|
Grant
|
Caveolin-1 and Cyclin D1 in Mammary Tumorigenesis
|
Grant
|
REGULATION OF CYCLIN D1 EXPRESSION
|
Grant
|
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
|
Grant
|
Initiation and Maintenance in Mammary Tumorigenesis
|
Grant
|
Impact of Cyclin D1 Isoforms in Breast Cancer
|
Academic Article
|
DACH1 suppresses breast cancer as a negative regulator of CD44.
|
Academic Article
|
CCR5 governs DNA damage and breast cancer stem cell expansion.
|
Academic Article
|
Recent advances of highly selective CDK4/6 inhibitors in breast cancer.
|
Academic Article
|
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth.
|
Academic Article
|
Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.
|
Academic Article
|
MAT1 correlates with molecular subtypes and predicts poor survival in breast cancer.
|
Academic Article
|
Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology.
|
Concept
|
Triple Negative Breast Neoplasms
|
Grant
|
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents
|
Academic Article
|
Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy.
|
Academic Article
|
piRNA-823 Is Involved in Cancer Stem Cell Regulation Through Altering DNA Methylation in Association With Luminal Breast Cancer.
|
Academic Article
|
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors.
|
Academic Article
|
The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance.
|
Academic Article
|
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.
|
Academic Article
|
Regulation of ERa-dependent breast cancer metastasis by a miR-29a signaling.
|
Academic Article
|
The Role and Therapeutic Targeting of CCR5 in Breast Cancer.
|